Author:
Gravel Patricia,Naik Aarti,Le Cotonnec Jean-Yves
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Cancer Research,Oncology
Reference66 articles.
1. R&D Pipeline news (2010) Top 30 Biologics 2010. March 3, 2011. Available from www.pipelinereview.com
2. Aapro M, Cornes P, Abraham I (2011) Comparative cost-efficiency across the European G5 countries of various regimens of filgrastim, biosimilar filgrastim, and pegfilgrastim to reduce the incidence of chemotherapy-induced febrile neutropenia. J Oncol Pharm Pract. doi: 10.1177/1078155211407367
3. Stewart A, Aubrey P, Belsey J (2010) Addressing the health technology assessment of biosimilar pharmaceuticals. Curr Med Res Opin 26:2119–2126
4. Arakawa T, Prestrelski SJ, Narhi LO, Boone TC, Kenney WC (1993) Cysteine 17 of recombinant human granulocyte-colony stimulating factor is partially solvent-exposed. J Protein Chem 12:525–531
5. Nagata S (1994) Granulocyte colony stimulating factor and its receptor. In: Thomson AW (ed) The cytokine handbook, 2nd. Academic, London, pp 371–385
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献